Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes

Journal of Biomedical Materials Research - Part A

Volumn 69, Issue 1, 2004, Pages 155-163

  Lopez Barcons, L A ^a,c   Polo, D ^b   Reig, F ^b   Fabra, A ^a  

^a Institut de Recerca Oncologica   (Spain)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Adriamycin; HT 1080; Liposomes; Targeting; YIGSR

Indexed keywords

BIOASSAY; DRUG THERAPY; GRAFTING (CHEMICAL); PROTEINS; TOXICITY;

CYTOTOXICITY;

CELL CULTURE;

DOXORUBICIN; DRUG CARRIER; FARMIBLASTINA; LAMININ 1; LIPOSOME; PENTAPEPTIDE; TYROSYLISOLEUCYLGLYCYLSERYLARGININE;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; COVALENT BOND; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG TARGETING; ENCAPSULATION; FIBROSARCOMA; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; STEREOCHEMISTRY;

EID: 1642415200     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.20235     Document Type: Article

References (31)

1. Young RC, Ozols RF, Myers CE. The anthracycline antineoplasic drugs. N Eng J Med 1981;305:139-153.
2. Blume G, Cevc G. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta 1990;1029:91-97.
3. Mori A, Klibanov, AL, Torchilin VP, Huang L. Influence of the steric barrier activity of amphipatic poly(ethyleneglycol) and ganglioside GM1 on the circulation of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett 1991; 284:263-266.
4. Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor mediated endocytosis. J Biol Chem 1994;269: 3198-3204.
5. Hansen CB, Kao GY, Moase EH, Zalipsky S, Allen TM. Attachment of antibodies to sterically stabilized liposomes: Evaluation, comparison and optimization of coupling procedures. Biochim Biophys Acta 1995;1239:133-144.
6. Kleinman HK, Cannon FB, Laurie GW, Hassell JR, Aumailley M, Terranova VP, Martin GR, DuBois-Dalq M. Biological activities of laminin. J Cell Biochem 1985;27:317-325.
7. Graf J, Iwamoto Y, Sasaki M, Martin GR, Kleinman HK, Robey FA, Yamada Y. Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis, and receptor binding. Cell 1987;48:989-996.
8. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG, Grigioni W. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 1991;4:239-246.
9. Yam HF, Chew EC, Chen HB, Wu S, Cheng-Chew SB, Yang L, Wang SW, Liew CT, Wu BQ. The 67 kD laminin receptor in high and low metastasis melanoma cell lines. Oncol Rep 1997; 4:115-118.
10. Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdan AF, Mulshine JL. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci USA 1990;87:6698-6702.
11. Sakamoto N, Iwahana M, Tanaka NG, Osada Y. Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide DPGYIGSR-NH2. Cancer Res 1991;51:903-906.
12. Grant DS, Tashiro K, Segui-Real B, Yamada Y, Martin GR, Kleinman HK. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 1989;58:933-943.
13. Yamamura K, Kibbey MC, Jun SH, Kleinman HK. Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis. Semin Cancer Biol 1993;4:259-265.
14. Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y, Martin GR. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 1987; 238:1132-1134.
15. Kawasaki K, Namikawa M, Murakami T, Mizuta T, Iwai T, Hama T, Mayumi T. Amino acid and peptides. XIV. Laminin related peptides and their inhibitory effect on experimental metastasis. Biochem Biophys Res Commun 1991;174:1159-1162.
16. Zalipsky S, Puntambekar B, Boulikas P, Engbers CM, Woodle MC. Peptide attachment to extremities of liposomal surface grafted PEG chains: Preparation of the long-circulating form of laminin pentapeptide, YIGSR. Bioconjugate Chem 1995;6:705-708.
17. Maruyama K, Takizawa T, Yuda T, Kennel SJ, Huang L, Iwatsuru M. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Biochim Biophys Acta 1995;1234:74-80.
18. Gabizon A, Dagan A, Goren D, Barenholz Y, Fuks Z. Liposomes as in vivo carriers of adriamycin: Reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res 1982;42:4734-4739.
19. Mc Clare CWF. An accurate and convenient organic phosphorous assay. Anal Biochem 1971;39:527-530.
20. Iwamoto Y, Nomizu M, Yamada Y, Ito Y, Tanaka K, Ugioka Y. Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma HT-1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR). Br J Cancer 1996;73:589-595.
21. Sonnenberg A., Linders CJT, Modderman PW, Damsky CA, Aumailley M, Timpl R. Integrin recognition of different fragments of laminin (P1, E3, E8) and evidence that α6β1 but not α6β4 functions as a major receptor for fragment E8. J Cell Biol 1990;110:2145-2155.
22. Alley MC, Scudeiro DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988;48:589-601.
23. Enoch HG, Strittmatter P. Formation and properties of 1000-Å-diameter, single-bilayer phospholipid vesicles. Proc Natl Acad Sci USA 1979;76:145-149.
24. Storm G, Roerdink FH, Steerenberg PA, Jong WH, Crommelin DJA. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res 1987;47:3366-3372.
25. Morikawa K, Walker SM, Nakajima N, Pathak S, Jessup JM, Fidler IJ. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 1988;48:6863-6871.
26. Horowitz AV, Barenholz Y, Gabizon A. In vitro cytotoxicity of liposome-encapsulated doxorubicin: Dependence on liposome composition and drug release. Biochim Biophys Acta 1992; 1109:203-209.
27. Liu LF. DNA topoisomerase poison as antitumor drugs. Annu Rev Biochem 1989;58:351-375.
28. Vichy P, Tritton TR. Adriamycin: Protection from cell death by removal of extracellular drug. Cancer Res 1992;52:4135-4138.
29. Tritton TR, Yee G. The anticancer agent adriamycin can be actively cytotoxic without entering the cells. Science 1982;217: 248-250.
30. Graf J, Ogle RC, Robey FA, Sasaki M, Martin GR, Yamada Y, Kleinman HK. A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67 000 laminin receptor. Biochemistry 1987;26:6900-6904.
31. Papahadjopoulos D, Allen TM, Gabizon A, Mayhew E, Matthay K, Huang SK, Lee KD, Woodle MC, Lasic DD, Redemann C, Martin FJ. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Prod Natl Acad Sci USA 1991;88:11460-11464.